Advertisement
Perrigo Guides FY24 Well Below Estimates - Update
(RTTNews) - While reporting financial results for the fourth quarter on Tuesday, consumer products company Perrigo Co. plc (PRGO) initiated its adjusted earnings, revenue and organic net sales growth guidance for the full-year 2024.
For fiscal 2024, the company now projects adjusted earnings in a range of $2.50 to $2.65 per share on flat net sales, with organic net sales growth of 1 to 3 percent.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.99 per share on revenue growth of 4.7 percent to $4.89 billion for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
Perrigo Recalls Select CVS Health, H-E-B Baby Premium Infant Formula
Perrigo Co. plc is recalling select Premium Infant Formula with Iron Milk-Based Powder sold under CVS Health and H-E-B Baby brands at the retailer and warehouse level citing elevated Vitamin D levels than permitted, according to the U.S. Food and Drug Administration. The recall involves three lots within one batch, or 16,500 cans, of store brand Premium Infant Formula with Iron Milk-Based Powder.
RTTNews
|
375 dias atrás
Perrigo Launches Project Energize To Improve Efficiency, Cut Costs; To Cut 6% Jobs - Update
While reporting financial results for the fourth quarter on Tuesday, consumer products company Perrigo Co. plc (PRGO) said it is launching Project Energize - a global investment and efficiency program to drive the next evolution of capabilities and organizational agility.
RTTNews
|
539 dias atrás
Perrigo Appoints Patrick Lockwood-Taylor As President And CEO
Pharma company Perrigo Company plc (PRGO) announced Thursday the appointment of industry professional Patrick Lockwood-Taylor as its new President, Chief Executive Officer and member of the Board of Directors, effective June 30, 2023.
RTTNews
|
803 dias atrás
Perrigo Says HRA Pharma Submits Application To FDA For OTC Birth Control Pill In The U.S.
Consumer Self-Care Products firm Perrigo Co. plc (PRGO) announced Monday that its company HRA Pharma has submitted its application to the U.S. Food and Drug Administration (FDA) for the first-ever over-the-counter (OTC) birth control pill in the U.S.
RTTNews
|
1135 dias atrás
FTSE 100 Modestly Higher
The UK stock market is modestly higher a little past noon on Tuesday amid expectations of a Ukraine peace deal. Investors are also looking ahead to the Federal Reserve's economic symposium at Jackson Hole, Wyoming, that gets underway on Thursday.
RTTNews
|
5 minutos atrás
Swiss Franc Rises Against Majors
The Swiss franc strengthened against other major currencies in the European session on Tuesday.
RTTNews
|
24 minutos atrás
CAC 40 Rises 0.8% As Ukraine Peace Deal Hopes Lift Sentiment
The French market is notably higher on Tuesday as investors pick up stocks amid hopes of a Russia - Ukraine peace deal after U.S. President Donald Trump described his meeting with Ukrainian President Volodymyr Zelenskyy and several other European leaders as "very good".
RTTNews
|
50 minutos atrás
Home Depot Q2 Profit Down, Misses Street, But Comps Rise; Backs FY25 Outlook
Home Depot Inc. reported Tuesday slightly lower profit in its second quarter, despite higher sales and comparable sales. Meanwhile, Adjusted earnings per share and top line missed market estimates. Further, the company maintained its outlook for fiscal 2025 earnings and sales growth.
RTTNews
|
56 minutos atrás
